Continuous glucose monitor for diabetes with kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if using a continuous glucose monitor (a sensor that checks your sugar levels all day) can improve blood sugar control in people with type 2 diabetes and kidney disease. You may join if your kidneys are at stage 3 or 4 (not on dialysis or transplant) and you take insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have type 2 diabetes and kidney function (eGFR) less than 60 for at least two checks in the last six months.
- Your diabetes treatment needs to be stable for the last 3 months and include insulin (basal, basal-bolus, or a mix with pills or a GLP-1 shot).
- You cannot have type 1 diabetes.
- You cannot be on dialysis or have had a kidney transplant.
- You need to be able to manage a continuous glucose monitor – no severe memory or thinking problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.